Title : Breast cancer therapy based on melatonin.

Pub. Date : 2012 May

PMID : 22369716






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 These actions are observable with physiologic doses of melatonin only in cells expressing ERalpha, and mediated by MT1 melatonin receptors. Melatonin estrogen receptor 1 Homo sapiens
2 This double action mechanism (SERM and SEEM), and the specificity for ERalpha bestows melatonin with potential advantages for breast cancer treatments, associated with other antiestrogenic drugs, and idea already patented. Melatonin estrogen receptor 1 Homo sapiens